Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Abbott introduces new drug for hyperparathyroidism in U.S.

May 15, 1998

Anergen receives SBIR grant for diabetes treatment development

May 15, 1998

Senetek's ED treatment shows 83% response rate

May 15, 1998

Alprox-TD efficacy established in Argentinian clinical trial

May 15, 1998

Connetics and Genentech expand Actimmune collaboration

May 14, 1998

FDA issues approvable letter for Roche's novel antiobesity Rx

May 14, 1998

New SERMs discovered at Lilly and claimed for estrogen-dependent disorders

May 13, 1998

Pfizer prepares new beta3-adrenoceptor agonists

May 13, 1998

Novartis begins phase III trial with Aredia in prostate cancer patients

May 12, 1998

Cysteine protease inhibitors synthesized at SKB claimed for osteoporosis, arthritis, periodontitis

May 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...